Advertisements



Vanda Pharmaceuticals denies allegations of "fraudulent schemes"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Vanda Pharmaceuticals denies allegations, "pleased" government not intervening

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Lexicon Falls as FDA Denies Approval to Type I Diabetes Drug

FDA issues complete response letter for Lexicon Pharmaceuticals (LXRX) and partner Sanofi's marketing application for .....»»

Category: dealsSource: nytMar 25th, 2019

Roche sues U.S. executives in fight over diabetes test strips

Roche is seeking tens of millions of dollars in damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker's latest case targeting what it calls fraudulent schemes involving its diabetes test strips......»»

Category: topSource: reutersMar 21st, 2019

First Week of May 17th Options Trading For Vanda Pharmaceuticals (VNDA)

Stock Options Channel.....»»

Category: topSource: redinewsMar 19th, 2019

Vanda Pharmaceuticals (VNDA) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow

Vanda Pharmaceuticals (VNDA) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow.....»»

Category: topSource: seekingalphaMar 11th, 2019

In First Interview Since Arrest, R. Kelly Denies Accusations of Sexual Abuse

In an interview to air on “CBS This Morning,” the singer, who faces charges involving underage girls, grew emotional when asked about allegations against him: “I didn’t do this stuff!”.....»»

Category: mediaSource: nytMar 7th, 2019

From Belk to Dick"s: Retailers deny Wilson company"s allegations in federal court

In a 20-page answer, Belk denies that it “engaged in any wrongdoing, caused any consumer confusion or engaged in any unfair competition.”.....»»

Category: topSource: bizjournalsFeb 25th, 2019

Huawei founder denies sharing secrets with Chinese government

In a series of interviews with Western news outlets, Ren Zhengfei is disputing allegations of cooperating with the Chinese government and cast U.S. legal action as "politically motivated.".....»»

Category: topSource: washpostFeb 19th, 2019

Vanda Pharmaceuticals: Strong Q4 2018 Results

Vanda Pharmaceuticals: Strong Q4 2018 Results.....»»

Category: topSource: seekingalphaFeb 19th, 2019

Huawei founder denies sharing secrets with China

In a series of interviews with Western news outlets, Ren Zhengfei is disputing allegations of cooperating with the Chinese government and cast U.S. legal action as "politically motivated.".....»»

Category: topSource: washpostFeb 19th, 2019

Huawei founder denies sharing secrets with China

In a series of interviews with Western news outlets, Ren Zhengfei is disputing allegations of cooperating with the Chinese government and cast U.S. legal action as "politically motivated.".....»»

Category: topSource: washpostFeb 19th, 2019

Vanda Pharmaceuticals price target lowered to $21 from $29 at Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2019

Vanda Pharmaceuticals, Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2018 Results - Earnings Call Transcript

Vanda Pharmaceuticals, Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 14th, 2019

Vanda Pharmaceuticals Inc (VNDA) Q4 2018 Earnings Conference Call Transcript

VNDA earnings call for the period ending December 31, 2018.....»»

Category: topSource: foxnewsFeb 14th, 2019

Vanda Pharmaceuticals (VNDA) Tops Q4 Earnings and Revenue Estimates

Vanda (VNDA) delivered earnings and revenue surprises of 100.00% and 3.33%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks Inv.....»»

Category: worldSource: nytFeb 13th, 2019

Vanda Pharmaceuticals (VNDA) Tops Q4 Earnings and Revenue Estimates

Zacks.....»»

Category: topSource: redinewsFeb 13th, 2019

Vanda Pharmaceuticals sees FY19 revenue $215M-$225M, consensus $246.66M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 13th, 2019

Vanda Pharmaceuticals reports Q4 EPS 26c, consensus 1c

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 13th, 2019

Vanda Pharmaceuticals under pressure as Aurelius Value discloses short position

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Vanda Pharmaceuticals named as short target by Aurelius Value

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019